Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism

Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism

Abstract Background Pioglitazone is a promising therapeutic method for nonalcoholic fatty liver disease (NAFLD) patients with or without type 2 diabetes. However, there is remarkable variability in treatment response. We analyzed our previous randomized controlled trial to examine the effects of gen...

Full description

Bibliographic Details
Main Authors: Hongmei Yan, Weiyun Wu, Xinxia Chang, Mingfeng Xia, Sicheng Ma, Liu Wang, Jian Gao
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Biology of Sex Differences
Subjects:
Pioglitazone
Gender
Liver fat content
Nonalcoholic fatty liver disease
Abnormal glucose metabolism
Online Access:https://doi.org/10.1186/s13293-020-00344-1

Internet

https://doi.org/10.1186/s13293-020-00344-1

Similar Items